Trials / Unknown
UnknownNCT04150302
Development and Validation of a Questionnaire to Measure the Impact of SBS and Its Treatments on Patients' Lives
Development and Validation of a Questionnaire to Measure the Impact of Short Bowel Syndrome (SBS) and Its Treatments on Patients' Lives
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Today, patients express a very strong need to take into account the consequences of their disease and its treatments in their therapeutic follow-up. It is therefore essential to better understand the needs, expectations and values of patients with SBS in order to better understand the impact of the disease on their lives, and thus improve the conditions for medical, social, psychological and technical care. The clinical expertise of health professionals and meetings with patient associations demonstrate the major gap between the parameters taken into account by physician to evaluate the evolution of the SBS and the day-to-day experience of the disease perceived by the patient. The objective of the ARTEMIS-GC study is to develop and validate an instrument to measure the impact of SBS and its treatments on daily life from the perspective of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exploratory interviews | Exploratory interviews to generate an interview guide |
| OTHER | Semi-directive interviews | Semi-directive interviews to collect qualitative data that will be used for questionnaire item generation |
| OTHER | Delphi Process | Cotation of newly developed items pertinence on a 4 points likert scale. |
| OTHER | Think aloud interviews | Debriefing session for the newly developed items: final possibility to adjust the tool before validating the psychometric proprieties of the questionnaire. |
| OTHER | Psychometric validation | Psychometric properties study |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2020-01-01
- Completion
- 2021-06-01
- First posted
- 2019-11-04
- Last updated
- 2019-11-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04150302. Inclusion in this directory is not an endorsement.